Sun Pharma Laboratories Limited v. Manisha Agarwal
Case brief
What is this about?
Bombay High Court Commercial Division; IA 2700/2025 in Commercial IP Suit 333/2025; Sun Pharma Laboratories Limited v. Manisha Agarwal; order dated 18-11-2025 by Sharmila U. Deshmukh, J.; extension of ad-interim injunction (prayer clauses (a) and (b)) against newly added Defendant Nos.4 and 5; ad-interim passing-off injunction granted per prayer clause (c); pharmaceutical marks 'OLIANCE-F'/'OLIANCE'/'OLIANCEF' versus registered mark 'OLEANZ'/'OLEAN'; prima facie deceptive similarity found on 13-03-2025; Court Receiver execution and document seizure on 07-04-2025 at Defendant No.3 premises implicating Defendant Nos.4 and 5 in sale/marketing; Plaintiff's sales turnover Rs.5985.86 lakhs (2023-2024); Defendant user since 2019, late entrant; leave under clause XIV of Letters Patent; next date 15-12-2025.
What did the court decide?
Ad-interim relief in terms of prayer clauses (a) and (b) extended against Defendant Nos.4 and 5; ad-interim relief granted in terms of prayer clause (c) (passing-off injunction restraining dealing in medicinal/pharmaceutical preparations under 'OLIANCE-F' or marks identical/deceptively similar to 'OLEAN'); ad-interim relief granted earlier to continue till the next date; application listed for further consideration on 15 December 2025.